Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) EBT Margin (2016 - 2023)

Historic EBT Margin for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to 9114.84%.

  • Cellectis' EBT Margin rose 42394500.0% to 9114.84% in Q3 2023 from the same period last year, while for Sep 2023 it was 245.16%, marking a year-over-year increase of 2968100.0%. This contributed to the annual value of 314.04% for FY2022, which is 2245100.0% down from last year.
  • Cellectis' EBT Margin amounted to 9114.84% in Q3 2023, which was up 42394500.0% from 1743.26% recorded in Q2 2023.
  • Over the past 5 years, Cellectis' EBT Margin peaked at 1743.26% during Q2 2023, and registered a low of 13354.29% during Q3 2022.
  • For the 5-year period, Cellectis' EBT Margin averaged around 2391.97%, with its median value being 509.72% (2021).
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -128445600bps in 2022, then surged by 42394500bps in 2023.
  • Over the past 5 years, Cellectis' EBT Margin (Quarter) stood at 870.34% in 2019, then soared by 67bps to 286.94% in 2020, then surged by 73bps to 78.67% in 2021, then grew by 5bps to 74.5% in 2022, then tumbled by -12135bps to 9114.84% in 2023.
  • Its EBT Margin was 9114.84% in Q3 2023, compared to 1743.26% in Q2 2023 and 12574.82% in Q1 2023.